An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

NCT03535766 | Completed

• 1 other identifier: 2/2018-014
• Study Type: observational
• Target: 2,100
• Locations: 1 country
• Sites: 1

Brief Summary

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Conditions

Lung Cancer

Outcome Measures

Primary Outcomes (1)

• Time from presentation to treatment

  Time from initial patient presentation with symptoms or incidental finding to first day of treatment, measured in days.

  from initial patient presentation with symptoms or incidental finding to first day of treatment, up to 3 years

Secondary Outcomes (1)

• Additional time between imaging and physician referrals

  From identification of concerning nodule to specialist appointment, up to 3 years

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion.

You may qualify if:

• Patient seen within the St. Elizabeth system
• \>=18 years of age
• New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later

You may not qualify if:

• Patients with metastatic lung disease of other primary
• Other malignancies at investigator's discretion
• Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC
• Patient currently undergoing treatment for new diagnosis of lung cancer

Sponsors & Collaborators

• St Elizabeth Healthcare: lead

Study Sites (1)

St. Elizabeth Healthcare

Edgewood, Kentucky, 41017, United States

Location

Related Publications (3)

• Diaconescu R, Lafond C, Whittom R. Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol. 2011 Jul;6(7):1254-9. doi: 10.1097/JTO.0b013e318217b623.

  PMID: 21610526 BACKGROUND

• Van de Vosse D, Chowdhury R, Boyce A, Halperin R. Wait Times Experienced by Lung Cancer Patients in the BC Southern Interior to Obtain Oncologic Care: Exploration of the Intervals from First Abnormal Imaging to Oncologic Treatment. Cureus. 2015 Sep 22;7(9):e330. doi: 10.7759/cureus.330.

  PMID: 26543688 BACKGROUND

• Vidaver RM, Shershneva MB, Hetzel SJ, Holden TR, Campbell TC. Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study. J Oncol Pract. 2016 Jun;12(6):e643-53. doi: 10.1200/JOP.2015.009605. Epub 2016 May 3.

  PMID: 27143146 BACKGROUND

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Royce Calhoun, MD

  St Elizabeth Healthcare

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 7, 2018
• First Posted: May 24, 2018
• Study Start: March 1, 2018
• Primary Completion: July 1, 2021
• Study Completion: January 9, 2023
• Last Updated: July 12, 2024

Record last verified: 2024-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)